GT Biopharma, Inc. (GTBP) Free cash flow 2016–2019
GT Biopharma, Inc. (GTBP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$3.7MFY2019 · since FY2016: -$1.9M → -$3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | -$3.7M | +65.8% |
| FY2018 | -$10.7M | -97.1% |
| FY2017 | -$5.4M | -181.6% |
| FY2016 | -$1.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GTBP financial trends
GTBP RevenueGTBP Net incomeGTBP Net marginGTBP Gross profitGTBP Gross marginGTBP Operating incomeGTBP Operating marginGTBP Operating cash flowGTBP Capital expendituresGTBP Return on equityGTBP Stock buybacksGTBP Dividends paidGTBP Total assetsGTBP Total liabilitiesGTBP Shareholders’ equityGTBP overview →